← Back to Search

Expressive Helping for Grief

N/A

Waitlist Available

Research Sponsored by University of California, Los Angeles

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline (≤2 weeks of starting the intervention), directly after each writing session, post-intervention survey (≤1 week after the final writing assignment), the 1-month follow-up, and 2-month follow up.

Awards & highlights

Study Summary

This trial tests a novel intervention combining elements of emotional disclosure and helping others who are also grieving. The study will compare the effects of this new intervention to those of traditional emotional disclosure and a control group who simply write about neutral topics.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline (≤2 weeks of starting the intervention), post-intervention survey (≤1 week after the final writing assignment), the 1-month follow-up, and 2-month follow up.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline (≤2 weeks of starting the intervention), post-intervention survey (≤1 week after the final writing assignment), the 1-month follow-up, and 2-month follow up.

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (≤2 weeks of starting the intervention), post-intervention survey (≤1 week after the final writing assignment), the 1-month follow-up, and 2-month follow up. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Grief Reactions

Change in Wellbeing

Secondary outcome measures

Change in Anxiety

Change in Depressive Symptoms

Change in Physical Symptoms

Other outcome measures

Change in Coping Tendency

Change in Generativity

Change in Psychological Distance

+1 more

Trial Design

3Treatment groups

Experimental Treatment

Active Control

Placebo Group

Group I: Expressive HelpingExperimental Treatment1 Intervention

Participants will be instructed to write about their deepest thoughts and feeling surrounding their bereavement experience in their first two essays and to provide advice and support for someone who recently experienced a loss in their final essay.

Group II: Expressive DisclosureActive Control1 Intervention

Participants will be instructed to write about their deepest thoughts and feelings surrounding their bereavement experience.

Group III: Fact-WritingPlacebo Group1 Intervention

Participants will be instructed to write objectively about different time frames (e.g., routine for getting up in the morning, routine for going to sleep at night).

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Expressive Helping

2022

Completed Phase 3

~710

Do I qualify?Apply below to find out